全文获取类型
收费全文 | 42667篇 |
免费 | 3021篇 |
国内免费 | 406篇 |
专业分类
耳鼻咽喉 | 806篇 |
儿科学 | 603篇 |
妇产科学 | 671篇 |
基础医学 | 6902篇 |
口腔科学 | 1015篇 |
临床医学 | 3718篇 |
内科学 | 8251篇 |
皮肤病学 | 1626篇 |
神经病学 | 3310篇 |
特种医学 | 2435篇 |
外科学 | 5371篇 |
综合类 | 252篇 |
现状与发展 | 4篇 |
一般理论 | 20篇 |
预防医学 | 1963篇 |
眼科学 | 1023篇 |
药学 | 3889篇 |
中国医学 | 579篇 |
肿瘤学 | 3656篇 |
出版年
2023年 | 286篇 |
2022年 | 968篇 |
2021年 | 1494篇 |
2020年 | 799篇 |
2019年 | 1154篇 |
2018年 | 1342篇 |
2017年 | 1076篇 |
2016年 | 1557篇 |
2015年 | 2092篇 |
2014年 | 2346篇 |
2013年 | 2670篇 |
2012年 | 3916篇 |
2011年 | 3674篇 |
2010年 | 2271篇 |
2009年 | 1833篇 |
2008年 | 2468篇 |
2007年 | 2252篇 |
2006年 | 1958篇 |
2005年 | 1878篇 |
2004年 | 1538篇 |
2003年 | 1332篇 |
2002年 | 1200篇 |
2001年 | 662篇 |
2000年 | 656篇 |
1999年 | 548篇 |
1998年 | 260篇 |
1997年 | 222篇 |
1996年 | 172篇 |
1995年 | 146篇 |
1994年 | 130篇 |
1993年 | 118篇 |
1992年 | 258篇 |
1991年 | 275篇 |
1990年 | 224篇 |
1989年 | 245篇 |
1988年 | 200篇 |
1987年 | 183篇 |
1986年 | 172篇 |
1985年 | 147篇 |
1984年 | 109篇 |
1983年 | 83篇 |
1982年 | 55篇 |
1981年 | 58篇 |
1980年 | 54篇 |
1979年 | 85篇 |
1978年 | 60篇 |
1975年 | 76篇 |
1974年 | 57篇 |
1972年 | 64篇 |
1971年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Yun Jeong Lim Young-Ho Kim Geung Hwan Ahn Ho Kwung Chun Woo Young Jang Jun Haeng Lee Hee Jung Son Poong-Lyul Rhee Jae J Kim Seung Woon Paik Byung Chul Yoo Jong Chul Rhee 《Taehan Sohwagi Hakhoe chi》2004,44(6):314-320
BACKGROUND/AIMS: Carcinogenesis is characterized by the abnormal regulation of cell cycle. The abnormal expression of the regulators of cell cycle may be related to the prognosis. Since the clinical significance of the expression of the three proteins in colorectal carcinomas is still controversial, we evaluated the prognostic value of the expression of cyclin E, p27 and mutant p53 in stage II colorectal cancer. METHODS: The expression levels of cyclin E, p27 and mutant p53 proteins in 41 patients with stage II colorectal carcinomas were analyzed by immunohistochemistry. RESULTS: In the univariate analysis, the level of CEA at diagnosis was associated with disease relapse. In the multivariate analysis, the clinicopathological variables such as age, gender, site of primary tumor, tumor size, state of tumor differentiation and preoperative plasma CEA level were not associated with disease relapse. When Kaplan-Meier survival curves were constructed to determine the prognosis, cyclin E, p27 and mutant p53 expressions did not predict poor prognosis. CONCLUSIONS: Our results suggested that the expression of cyclin E, p27 and mutant p53 proteins did not predict the clinical outcome in the stage II colorectal carcinomas. 相似文献
92.
93.
Kyung‐Sub Moon Shin Jung Jae‐Hyuk Lee Tae‐Young Jung In‐Young Kim Soo‐Han Kim Sam‐Suk Kang 《Neuropathology》2006,26(2):141-146
We present a case of benign osteoblastoma of the occipital bone. Benign osteoblastoma is an uncommon primary bone tumor, which usually involves the vertebrae and the long bones. This tumor rarely develops in the calvaria, showing a preference for the temporal and frontal bones when it does. To the best of our knowledge, this case is only the eighth reported case of benign osteoblastoma confined to the occipital bone. A 20‐year‐old male presented with a mild tender mass lesion of the occipital area, just below the lambda. Plain X‐ray films and CT scans demonstrated an osteolytic mass surrounded by the sclerotic rim within the diploic space. MRI proved to be effective for the evaluation of the intracranial and intraosseous extensions of the tumor. However, it was very difficult to formulate a differential diagnosis against other osteoblastic tumors, or osteoid osteoma, in view of its radiological appearance. The final diagnosis was obtained by careful consideration of the histopathological characteristics of the tumor combined with its clinical and radiological features. Although generally regarded as benign, a complete resection is preferred over conventional curettage as this can guard against possible recurrence and malignant transformation. 相似文献
94.
Joong-Yang Cho Jung Joon Sung Ju-Hong Min Kwang-Woo Lee 《Journal of clinical neuroscience》2006,13(9):908-912
Needle electromyography (EMG) and determining the motor evoked potential (MEP) of the genioglossus (tongue) are difficult to perform in evaluation of the craniobulbar region in patients with amyotrophic lateral sclerosis (ALS). Needle EMG and MEP determination in the upper trapezius were carried out in 17 consecutive ALS patients. The needle EMG parameters recorded included abnormal spontaneous activity and motor unit action potential morphology. An upper motor neuron lesion was presumed when either response to cortical stimulation was absent, or the central conduction time was delayed (>mean + 2 SD). Of the 12 patients with limb-onset ALS, using needle EMG, 11 were found to have abnormalities in the upper trapezius, and only five in the tongue. Three of the six patients with isolated limb involvement had abnormal MEP findings. In conclusion, electrophysiological studies of the upper trapezius are useful in ALS patients without bulbar symptoms. 相似文献
95.
Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig. 总被引:3,自引:0,他引:3
L C De Boer P A Steerenberg P M Van der Meijden B Van Klingeren W H De Jong A Elgersma F M Debruyne E J Ruitenberg 《The Journal of urology》1992,148(5):1577-1582
At present, isoniazid (INH) is being used prophylactically to reduce the side effects of intravesical BCG therapy for superficial bladder cancer, although it is not clear whether or not this reduces the antitumor efficacy of BCG. In this study the impact of INH treatment on the immune response after repeated intravesical BCG administration was investigated in guinea pigs. INH was given on the 3 days around each BCG instillation. We found that the administration of INH severely impaired the immunological effects of BCG. The induction of mononuclear cell infiltration in the bladder wall was reduced. Enlargement of the regional lymph nodes (weight and number of cells), and increase of MHC Class II expression on the lymph node cells, normally observed after intravesical BCG administration, were inhibited by INH. Systemic immunity, measured by the DTH reaction in the skin to PPD, was also diminished due to the combined treatment of BCG with INH. When INH was administered during the last 4 of 6 BCG instillations, the immune response to BCG was still impaired. A five-fold increase of the dose of BCG did not overcome the effect of INH. INH probably did not exert a direct suppression of the immune system of the guinea pig as the DNCB skin reactivity was not influenced. Although INH concentrations in the urine were high at the onset of the instillation, in vitro experiments indicated that the effect of INH may not be caused by killing of the BCG organisms shortly after application in the bladder. In conclusion, our data in guinea pigs suggest that the use of INH may impair the immune response to intravesical BCG. As this response may be important for the antitumor effect of BCG, urologists should be cautious with the prophylactic use of INH. The influence on the antitumor efficacy is now investigated in man. 相似文献
96.
Alpha-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in rats. 下载免费PDF全文
P. L. van Giersbergen E. van Duinkerken C. G. Sweep V. M. Wiegant J. M. van Ree W. de Jong 《British journal of pharmacology》1990,99(3):467-472
1. This study served to investigate whether endogenous opioid peptides play a role in the putative antinociceptive and the sedative actions of alpha-methyldopa. 2. In conscious normotensive rats, alpha-methyldopa induced hypotension, starting around 1 h and reaching a maximum 3-4 h after administration. Pretreatment with naltrexone resulted in an inhibition of alpha-methyldopa-induced hypotension. 3. alpha-Methyldopa dose-dependently increased hot plate latency which became evident after a 4 h lag period and reaching a maximum effect at 6 h. The antinociceptive effect of alpha-methyldopa was not affected by naltrexone. 4. In a small open field, alpha-methyldopa dose-dependently suppressed locomotion and sniffing behaviour. These effects of alpha-methyldopa were apparent 1 h after administration and were naltrexone-insensitive. 5. No changes in the level of beta-endorphin-like immunoreactivity in plasma and cerebrospinal fluid were observed after administration of alpha-methyldopa. 6. The results indicate that endogenous opioid peptides are involved in the hypotensive action of alpha-methyldopa but not in alpha-methyldopa-induced hypomotility and antinociception. 相似文献
97.
Nicole C. Naus Gregorius P. M. Luyten Theo Stijnen Paul T. V. M. De Jong 《Documenta ophthalmologica. Advances in ophthalmology》1995,90(1):53-59
In this study we wanted to investigate the post-operative astigmatism and visual acuity after phacoemulsification and conventional extracapsular cataract surgery. Patients operated between April and June 1993 (n=150) were retrospectively analyzed. The patients were examined prior to surgery and at day 1, at day 10, and in week 6 post-operatively. The difference between the post-operative log mean visual acuity in the Phaco group and in the CECCE group was significant after 1 and 10 days, however it was not significant (p=0.191) after 6 weeks. The mean astigmatism was significantly less in the Phaco group than in the CECCE group during the whole post-operative check-up period. This study suggests that Phaco results in a lower post-operative astigmatism and an earlier visual rehabilitation compared to the CECCE technique.Abbreviations Phaco
Phacoemulsification
- CECCE
Conventional extracapsular cataract extraction 相似文献
98.
Acute surgical abdomen is the object of urgent surgical attention. The objective of emergency operation is to interrupt a process that has a steadily worsening prognosis on a scale of hours unless effective surgical treatment is rendered. There are basically three processes to address: free or incipient sepsis and peritonitis, gastrointestinal soilage, and hemorrhage. 相似文献
99.
Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist 总被引:6,自引:0,他引:6
A A Connacher R T Jung P E Mitchell 《British medical journal (Clinical research ed.)》1988,296(6631):1217-1220
A double blind placebo controlled study was carried out in 40 subjects newly referred for treatment for obesity to determine the effects of the new thermogenic beta adrenoceptor agonist BRL 26830A. The subjects were randomised to receive either BRL 26830A, 200 mg daily for two weeks then 400 mg daily, or placebo for 18 weeks, and all were instructed to follow a 3.35 MJ diet that was low in fat and high in fibre. Weight loss was 15.4 (SD 6.6) kg in subjects given BRL 26830A compared with 10.0 (5.9) kg in those given placebo (p = 0.02). The relative weight loss was 0.93 (0.39%) a week with BRL 26830A and 0.61 (0.38)% with placebo (p = 0.02). Urinary excretion of nitrogen was similar in both groups, whereas measurements of skinfold thickness indicated a 4.1 kg difference in the amount of fat lost, suggesting that weight loss with BRL 26830A was mainly from adipose and not lean tissue. BRL 26830A had no effect on resting pulse rate or pressor effects on either diastolic or systolic blood pressure. No significant differences were found between the two groups in serum cholesterol concentration, percentage of high density lipoprotein cholesterol, plasma concentrations of glucose and insulin, the ratio of glucose to insulin, serum concentrations of triiodothyronine and thyroxine, and creatinine clearance. Short term administration of BRL 26830A to six subjects who had taken the drug for 18 weeks showed that the expenditure of energy increased by 11.6% during the second hour after administration, which suggests that BRL 26830A may enhance weight loss thermogenically. BRL 26830A may be a useful drug in the treatment of obesity. 相似文献
100.
S. Stegemann F. Leveiller D. Franchi H. de Jong H. Lindn 《European journal of pharmaceutical sciences》2007,31(5):249-261
Drug absorption, sufficient and reproducible bioavailability and/or pharmacokinetic profile in humans are recognized today as one of the major challenges in oral delivery of new drug substances. The issue arose especially when drug discovery and medicinal chemistry moved from wet chemistry to combinatorial chemistry and high throughput screening in the mid-1990s. Taking into account the drug product development times of 8–12 years, the apparent R&D productivity gap as determined by the number of products in late stage clinical development today, is the result of the drug discovery and formulation development in the late 1990s, which were the early and enthusiastic times of the combinatorial chemistry and high throughput screening. In parallel to implementation of these new technologies, tremendous knowledge has been accumulated on biological factors like transporters, metabolizing enzymes and efflux systems as well as on the physicochemical characteristics of the drug substances like crystal structures and salt formation impacting oral bioavailability. Research tools and technologies have been, are and will be developed to assess the impact of these factors on drug absorption for the new chemical entities.
The conference focused specifically on the impact of compounds with poor solubility on analytical evaluation, prediction of oral absorption, substance selection, material and formulation strategies and development. The existing tools and technologies, their potential utilization throughout the drug development process and the directions for further research to overcome existing gaps and influence these drug characteristics were discussed in detail. 相似文献